cardiovascular-agents and sulprostone

cardiovascular-agents has been researched along with sulprostone* in 2 studies

Other Studies

2 other study(ies) available for cardiovascular-agents and sulprostone

Article	Year
Peripartum cardiomyopathy vs. sulprostone-associated heart failure? A case report and analysis of the literature. Archives of gynecology and obstetrics, 2013, Volume: 288, Issue:6 Topics: Adult; Cardiomyopathy, Dilated; Cardiovascular Agents; Dinoprostone; Echocardiography; Female; Heart Failure; Humans; Peripartum Period; Postpartum Hemorrhage; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Treatment Outcome	2013
Influence of the PG-analogues iloprost, nalador and nileprost on rejection time and TXB2 content of murine tail skin allografts. Biomedica biochimica acta, 1988, Volume: 47, Issue:10-11 Iloprost (2 X 330 micrograms/kg sc./d) better than nalador (2 X 500 micrograms/kg sc./d) prolonged the average time until the complete rejection of murine tail skin allografts in inbred mice. Nileprost (2 X 500 micrograms/kg sc./d) showed a similar trend. The TXB2 content in the ambient skin at the transplantation site was significantly diminished by all three PG-analogues, but by nileprost more than by iloprost or nalador. Topics: Animals; Cardiovascular Agents; Dinoprostone; Epoprostenol; Female; Graft Rejection; Iloprost; Mice; Mice, Inbred C57BL; Prostaglandins E, Synthetic; Reference Values; Skin; Skin Transplantation; Thromboxane B2; Transplantation, Homologous	1988

Article

Year

Peripartum cardiomyopathy vs. sulprostone-associated heart failure? A case report and analysis of the literature.

Archives of gynecology and obstetrics, 2013, Volume: 288, Issue:6

Topics: Adult; Cardiomyopathy, Dilated; Cardiovascular Agents; Dinoprostone; Echocardiography; Female; Heart Failure; Humans; Peripartum Period; Postpartum Hemorrhage; Pregnancy; Pregnancy Complications, Cardiovascular; Puerperal Disorders; Treatment Outcome

2013

Influence of the PG-analogues iloprost, nalador and nileprost on rejection time and TXB2 content of murine tail skin allografts.

Biomedica biochimica acta, 1988, Volume: 47, Issue:10-11

Iloprost (2 X 330 micrograms/kg sc./d) better than nalador (2 X 500 micrograms/kg sc./d) prolonged the average time until the complete rejection of murine tail skin allografts in inbred mice. Nileprost (2 X 500 micrograms/kg sc./d) showed a similar trend. The TXB2 content in the ambient skin at the transplantation site was significantly diminished by all three PG-analogues, but by nileprost more than by iloprost or nalador.

Topics: Animals; Cardiovascular Agents; Dinoprostone; Epoprostenol; Female; Graft Rejection; Iloprost; Mice; Mice, Inbred C57BL; Prostaglandins E, Synthetic; Reference Values; Skin; Skin Transplantation; Thromboxane B2; Transplantation, Homologous

1988